We speculate that these cases (representing 33% of NPM1-mutated cases) may contain too few AML immature cells for classification into NPM1class I or NPM1class II based on bulk RNA-seq data and would require scRNA-seq to be accurately classified. The gene discussed is NPM1; the disease is acute myeloid leukemia.